5 Best Performing Healthcare Stocks So Far in 2026

3. Tango Therapeutics, Inc. (NASDAQ:TNGX)

YTD Share Price Gain: 171.01%

Tango Therapeutics, Inc. (NASDAQ:TNGX) is one of the best performing healthcare stocks so far in 2026. Stifel lifted the price target on Tango Therapeutics, Inc. (NASDAQ:TNGX) to $40 from $24 on April 27, maintaining a Buy rating on the shares. The firm cited elevated conviction for the PRMT5 inhibitor + RAS(ON) inhibitor synergy in pancreatic ductal adenocarcinoma.

For additional context, Tango Therapeutics, Inc. (NASDAQ:TNGX) reported in its fiscal Q4 and full year 2025 results that it held $343.1 million in cash, cash equivalents, and marketable securities, which it expects to fund operations into 2028. It further reported that collaboration revenue for the quarter was $0 compared to $5.4 million for the same period in 2024, and $62.4 million for the full year, compared to $30.0 million for the prior year period.

It added that all of the remaining deferred revenue under the Gilead collaboration was recognized as collaboration revenue during fiscal Q3 2025 as a result of the truncation of the collaboration agreement, which concluded all research activities.

Tango Therapeutics, Inc. (NASDAQ:TNGX) is a clinical-stage biotechnology company that discovers and delivers precision cancer medicines. The company is also involved in the identification of novel targets and the development of new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need.